Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Clinical research

Omalizumab reduces colds in children with asthma

Children treated with omalizumab had 27% fewer colds then those treated with guideline-based care.

Omalizumab, a biologic that targets immunoglobulin E (IgE), can reduce viral-induced asthma exacerbations in patients with allergic asthma. However, little is known about its effect on colds. 

Researchers randomly assigned 478 children (aged 6–17 years) with allergic asthma to receive guideline-based care only or guideline-based care plus fluticasone or omalizumab. Treatment took place over four months during autumn, when colds are more common. 

Children treated with omalizumab had 27% fewer colds than children assigned to guideline-based care. This reduction was observed in both those with moderate and severe-persistent asthma. In contrast, fluticasone had no effect on cold rates. 

The researchers, who reported their results at a conference in Los Angeles, California, on 4–7 March 2016[1], say the findings support the idea that by reducing IgE levels, omalizumab increases interferon responses, leading to better protection against viruses.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200892

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Pre-teen boy using an inhaler

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.